Brief: Immix Biopharma Plans To Partner-Out Other Serious Disease Programs
06/08/2025 17:39
Aug 6 (Reuters) - Immix Biopharma Inc IMMX.O: IMMIX BIOPHARMA ANNOUNCES OTHER SERIOUS DISEASES STRATEGY IMMIX BIOPHARMA INC: COMPANY PLANS TO PARTNER-OUT OTHER SERIOUS DISEASE PROGRAMS IMMIX BIOPHARMA INC: DOSING ONGOING AND PLANNED IN A HANDFUL OF OTHER SERIOUS DISEASES Source text: ID:nGNE76Kj5B Further company coverage: IMMX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary